Lifecore Biomedical, Inc. has announced a new agreement with Nirsum Laboratories, Inc. to support the clinical development of Nirsum’s lead candidate, NRS-033. The collaboration will focus on fill and finish technology transfer, a key component in the development and commercialisation
Lifecore Biomedical, Inc. has been selected by Lindy Biosciences to provide contract development and manufacturing services (CDMO) for the company’s microglassification technology. The partnership aims to streamline the formulation process and scale the technology for commercial manufacturing, with a multi-year
Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organisation (CDMO), has announced that its high-speed, 5-head isolator filler is now GMP-ready and operational. This new equipment, designed for fill/finish services, will support prefilled syringes, vials, and cartridges, while
Lifecore Biomedical Contract Manufacturing & Development (CDMO) Profile CDMO | Sodium Hyaluronate Producer | Sterile Injectable CDMO | Lifecore Lifecore is a CDMO and Sodium Hyaluronate producer that manufactures clinical and commercial sterile injectable drug products. With our automated, online
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
